Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 2
2020 1
2021 2
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Orchestrating and sharing large multimodal data for transparent and reproducible research.
Mammoliti A, Smirnov P, Nakano M, Safikhani Z, Eeles C, Seo H, Nair SK, Mer AS, Smith I, Ho C, Beri G, Kusko R; Massive Analysis Quality Control (MAQC) Society Board of Directors; Lin E, Yu Y, Martin S, Hafner M, Haibe-Kains B. Mammoliti A, et al. Nat Commun. 2021 Oct 4;12(1):5797. doi: 10.1038/s41467-021-25974-w. Nat Commun. 2021. PMID: 34608132 Free PMC article.
Consensus on Molecular Subtypes of High-Grade Serous Ovarian Carcinoma.
Chen GM, Kannan L, Geistlinger L, Kofia V, Safikhani Z, Gendoo DMA, Parmigiani G, Birrer M, Haibe-Kains B, Waldron L. Chen GM, et al. Clin Cancer Res. 2018 Oct 15;24(20):5037-5047. doi: 10.1158/1078-0432.CCR-18-0784. Epub 2018 Jul 3. Clin Cancer Res. 2018. PMID: 30084834 Free PMC article.
Hypophagia induced by intracerebroventricular injection of apelin-13 is mediated via CRF1/CRF2 and MC3/MC4 receptors in neonatal broiler chicken.
Safikhani A, Zendehdel M, Khodadadi M, Rahmani B, Ghashghayi E, Mahdavi K. Safikhani A, et al. Behav Brain Res. 2023 Aug 24;452:114536. doi: 10.1016/j.bbr.2023.114536. Epub 2023 Jun 8. Behav Brain Res. 2023. PMID: 37295613
Experiments 3 through 8 were quite similar to experiment 2, with the exception of astressin2-B (CRF2 receptor antagonist, 30 g), SHU9119 (MC3/MC4 receptor antagonist, 0.5 nmol), MCL0020 (MC4 receptor antagonist, 0.5 nmol), BIBP-3226 (NPY1 receptor antagonist, 1.25 nmol), BIIE 024 …
Experiments 3 through 8 were quite similar to experiment 2, with the exception of astressin2-B (CRF2 receptor antagonist, 30 g), SHU9119 (MC …